Life Sciences Tools and Services
Daily Stock Watch: Is Veeva Systems a Buy?
Shares of Veeva Systems Inc (NYSE: VEEV) are markedly lower on Friday on the back of earnings disappointment. But with few competitors and a...
Why Investing in Biopharma Could Boost Your Portfolio
Are biopharma stocks the missing secret ingredient for your portfolio? Read on to find out why investing in biopharma could leave you with sizeable...
Is Achieve Life Sciences Stock a Buy?
Achieve Life Sciences (NASDAQ: ACHV) is developing a treatment to help smokers quit cigarettes and e-cigarettes.
Top Cannabis Penny Stocks to Consider
With weed legalization legislation introduced to the Senate earlier this summer, savvy investors might be keen to work out the best cannabis penny...
Is Investing in Shroom Stocks a Good Idea?
Shroom stocks, otherwise known as psychedelic stocks, present an early-stage investment opportunity that could result in mainstream health treatments.
Daily Stock Watch: APDN Stock Leaps by Over 100%
Applied DNA Sciences (NASDAQ: APDN) has seen its share price more than double after big news for its clinical laboratory subsidiary. Is APDN stock...
Is Legend Biotech Stock a Solid Investment?
With major backing and a promising lead product candidate, Legend Biotech stock looks like an exciting investment opportunity. But is this life...
Daily Stock Watch: Danaher (DHR) Share Price Rises
The Danaher (NASDAQ: DHR) share price is rising as Q2 results please investors. Does this mean Danaher stock is a buy?
What is Life Sciences and Should You Invest?
Investment in Life Sciences has exploded in recent years. But what is Life Sciences? Read on to discover the nature-based opportunities in this field.
Open Orphan hails “transformation” as results deliver on promises
Open Orphan is making headlines as the Covid-19 pandemic highlights the importance of its work in the infectious diseases space.
Open Orphan branches out amid infectious disease gold rush
A new wave of research into malaria treatments has kicked off over the last 18 months. Which is great news for clinical research organisation Open...